Skip to main content
SpringerLink
Log in

Immunopathogenesis, Immunization, and Treatment of Infectious Diseases

  • Chapter
  • First Online:
Book cover Pharmacology of Immunotherapeutic Drugs

Abstract

The immune system is critical for human survival and protects the host from invasion by pathogenic microorganisms. Knowledge of the mechanisms by which the immune system eradicates pathogens as well as those involved in the evasion of immune responses by pathogens has led to significant advances in the effort to combat the threat of infectious diseases. This includes the development of vaccination as a means to prevent and eradicate various infectious diseases and the development of drugs that target different stages of pathogen life cycle in human cells. In this chapter, the mechanisms underlying vaccination will be discussed as well as the various vaccines that are currently prescribed in the United States. The chapter also discusses the immunopathogenesis of infectious diseases such as Acquired Immune Deficiency Syndrome and tuberculosis, and examine the immune mechanisms involved in the development of sepsis, septic shock, and toxic shock syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.

    Article  CAS  PubMed  Google Scholar 

  • Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Blackwell TS, Christmas JW. Sepsis and cytokines: current status. Br J Anaesth. 1996;77:110–7.

    Article  CAS  PubMed  Google Scholar 

  • Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, Nagarkatti M. Role of cytokines as a double-edged sword in sepsis. In Vivo. 2013;27(6):669–84.

    CAS  PubMed  Google Scholar 

  • Cooper AM. Cell mediated immune responses in tuberculosis. Annu Rev Immunol. 2009;27:393–422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cox MM, Hollister JR. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals. 2009;37(3):182–9.

    Article  CAS  PubMed  Google Scholar 

  • Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A, et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health. 2017;2(1):e35–46.

    Article  PubMed  Google Scholar 

  • DiazGranadose CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45.

    Article  Google Scholar 

  • Eshelman E, Shahzad A, Cohrs RJ. Varicella zoster latency. Future Virol. 2001;6(3):341–55.

    Article  Google Scholar 

  • Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167–74.

    Article  PubMed  Google Scholar 

  • Gardlund B. Activated protein C (Xigris) treatment in sepsis: a drug in trouble. Acta Anaesthesiol Scand. 2006;50(8):907–10.

    Article  CAS  PubMed  Google Scholar 

  • Grimaldi D, Turcott EWG, Taccone FS. IL-1 receptor antagonist in sepsis: new findings with old data? J Thorac Dis. 2016;8(9):2379–82.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gul F, Arslantas MK, Cinel I, Kumar A. Changing definitions of sepsis. Turk J Anaesthesiol Reanim. 2017;45(3):129–38.

    Article  PubMed  PubMed Central  Google Scholar 

  • Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection- an update. Microb Cell. 2016;3(9):420–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14(5):315–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • King EG, Bauzá GJ, Mella JR, Remick DG. Pathophysiologic mechanisms in septic shock. Lab Invest. 2014;94(1):4–12.

    Article  CAS  PubMed  Google Scholar 

  • Korb VC, Chuturgoon AA, Moodley D. Mycobacterium tuberculosis:manipulator of protective immunity. Int J Mol Sci. 2016;17(3):131.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kraft R, Herndon DN, Finnerty CC, Cox RA, Song J, Jeschke MG. Predictive value of IL-8 for sepsis and severe infections after burn injury—a clinical study. Shock. 2015;43(3):222–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med. 2010;363:2036–44.

    Article  CAS  PubMed  Google Scholar 

  • Lee YT, Kim KH, Ko EJ, Lee YN, Kim MC, Kwon YM, et al. New vaccines against influenza virus. Clin Exp Vaccine Res. 2014;3(1):12–28.

    Article  CAS  PubMed  Google Scholar 

  • Lepak A, Andes D. Fungal sepsis: optimizing antifungal therapy in the critical care setting. Crit Care Clin. 2011;27(1):123–47.

    Article  CAS  PubMed  Google Scholar 

  • Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit Care Clin. 2013;29(3):651–75.

    Article  PubMed  Google Scholar 

  • Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–54.

    Article  PubMed  Google Scholar 

  • Modlin RL. The innate immune response in leprosy. Curr Opin Immunol. 2010;22(1):48–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nascimento IP, Leite LCC. Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res. 2012;45(12):1102–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nyamweya S, Hegedus A, Jaye A, Rowland-Jones S, Flanagan KL, Macallan DC. Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis. Rev Med Virol. 2013;23(4):221–40.

    Article  CAS  PubMed  Google Scholar 

  • Plotkin S, Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009;48(4):456–61.

    Article  Google Scholar 

  • Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011;12(6):509–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rao TS, Andrade C. The MMR vaccine and autism: sensation, refutation, retraction, and fraud. Indian J Psychiatry. 2011;53(2):95.

    Article  PubMed  PubMed Central  Google Scholar 

  • Remick DG. Pathophysiology of Sepsis. Am J Pathol. 2007;170(5):1435–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: interleukin-6 measured 6h after the initiation of sepsis predicts mortality over 3 days. Shock. 2002;17(6):463–7.

    Article  PubMed  Google Scholar 

  • Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017a;43(3):304–77.

    Article  PubMed  Google Scholar 

  • Rhodes A, Evans L, Alhazzani W, et al. Surviving sepsis campaign. Crit Care Med. 2017b;45(3):486–552.658.

    Article  PubMed  Google Scholar 

  • Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle path (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled phase I trial. Lancet. 2017;390(10095):649–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). J Am Med Assoc. 2016;315(8):801–10.

    Article  CAS  Google Scholar 

  • Smith KA. Louis Pasteur, the father of immunology? Front Immunol. 2012;3(68):1–10.

    PubMed  PubMed Central  Google Scholar 

  • Srisangthong P, Wongsa A, Kittiworawitkul P, Wattanathum A. Early IL-6 response is correlated with mortality and severity score. Crit Care. 2013;17(Suppl 2):P34.

    Article  PubMed Central  Google Scholar 

  • Stach CS, Herrera A, Schlievert PM. Staphylococcal superantigens interact with multiple host receptors to cause serious diseases. Immunol Res. 2014;59(1–3):177–81.

    Article  PubMed  PubMed Central  Google Scholar 

  • Suarez De La Rica A, Gilsanz F, Maseda E. Epidemiologic trends of sepsis in western countries. Ann Transl Med. 2016;4(17):325.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wesche-Soldato DE, Lomas-Neira JL, Perl M, Jones L, Chung CS, Ayala A. The role and regulation of apoptosis in sepsis. J Endotoxin Res. 2005;11(6):375–82.

    Article  CAS  PubMed  Google Scholar 

  • Wesche-Soldato DE, Swan RZ, Chung CS, Ayala A. The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets. 2007a;8(4):493–500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wesche-Soldato DE, Chung CS, Gregory SH, Salazar-Mather TP, Ayala CA, Ayala A. CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am J Pathol. 2007b;171(1):87–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med. 2017;376:305–17.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of Saint Joseph, Hartford, CT, USA

    Doreen E. Szollosi

  2. School of Pharmacy and Physician Assistant Studies, University of Saint Joseph, Hartford, CT, USA

    Sunna Ahmad

  3. Department of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA, USA

    Clinton B. Mathias

  4. Yale New Haven Hospital, New Haven, CT, USA

    Victoria Lucero

  5. St. Vincent’s Medical Center, Bridgeport, CT, USA

    Jennifer Donato

Authors
  1. Doreen E. Szollosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clinton B. Mathias
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victoria Lucero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sunna Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jennifer Donato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Doreen E. Szollosi .

Editor information

Editors and Affiliations

  1. Department of Pharmaceutical and Administrative Sciences College of Pharmacy and Health Sciences, Western New England University, Springfield, MA, USA

    Clinton B. Mathias

  2. Pharmaceutical Science and Research School of Pharmacy, Marshall University, Huntington, WV, USA

    Jeremy P. McAleer

  3. Department of Pharmaceutical Sciences School of Pharmacy and Physician Assistant Studies, University of Saint Joseph, Hartford, CT, USA

    Doreen E. Szollosi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Szollosi, D.E., Mathias, C.B., Lucero, V., Ahmad, S., Donato, J. (2020). Immunopathogenesis, Immunization, and Treatment of Infectious Diseases. In: Mathias, C., McAleer, J., Szollosi, D. (eds) Pharmacology of Immunotherapeutic Drugs. Springer, Cham. https://doi.org/10.1007/978-3-030-19922-7_9

Download citation

Publish with us

Policies and ethics

Search

Navigation